Wet blood spot: unlocking new horizons for blood testing
About the webinar
Wet blood spot technology is a method used to collect and analyze small samples of blood on filter paper. Unlike dried blood spot (DBS) technology, where blood is allowed to dry on the filter paper, wet blood spot technology maintains the blood sample in a wet or liquid state until analysis, allowing to preserve and recover fresh blood cells of high quality.
Different applications across the healthcare sector can benefit from the wet blood spot. During this webinar, Ahlstrom and Metafora Biosystems will discuss the use of wet blood spot collection cards for simple and efficient screening of the GLUT1 Deficiency Syndrome, a rare neurometabolic syndrome caused by a defect in the glucose transporter GLUT1, leading to a cerebral energy deficit. The assay leverages the capability of the wet blood spot to preserve red blood cells for antigen quantitation.
Furthermore, this approach can offer numerous advantages including enhanced sensitivity, as some analytes (biological molecules or chemical compounds) may be more stable or easier to detect in a wet state. It also allows for immediate processing and increased accuracy by reducing variability introduced by the drying process.
Meet the speakers
Marco Consiglio, Head of Product Management Lab & Life Science, Ahlstrom
As Head of Product Management at Ahlstrom, Marco Consiglio is in charge of managing the R&D and Product Management team for the Laboratory and Life Science product categories, which include components for rapid test kits, biospecimen collection cards, and filter media for sample preparation. Marco holds an MSc in Reproductive Medicine and Medical Biotechnology from the University of Turin.
marco.consiglio@ahlstrom.com
Vincent Petit, DMV, PhD Co-Founder & Chief Executive Officer (CEO), Metafora Biosystems
Vincent is a co-founder and CEO of METAFORA, with a strong background in scientific research and business development, he played a crucial role in incubating the company from its inception. His expertise spans across basic science, translational research, and the seamless integration of scientific discoveries into industrial solutions. Vincent holds a Doctor of Veterinary Medicine (DVM) degree from the prestigious National Veterinary School of Alfort in France. He further advanced his academic pursuits by obtaining a PhD in cell biology and microbiology from the esteemed Pasteur Institute and the Paris University (Université Denis Diderot – Paris VII, France).
vincent.petit@metafora-biosystems.com